chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, Computerised tomogram, Magnetic resonance imaging, Muscular weakness
Clinical narrative: Guillian-Barre Syndrome; Back pain; muscle weakness; muscle strain; This is a spontaneous report received from a contactable consumer (patient). A 58-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration at the age of  58-years-old, administered in Arm Right on 17Mar2021 10:30 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included scoliosis. The patient was not pregnant. Concomitant medications included cranberry (CRANBERRY) and plantago ovata (PSYLLIUM HUSK [PLANTAGO OVATA]), both taken for an unspecified indication, start and stop date were not reported, and an unspecified multivitamin. The patient previously took MACROBID [nitrofurantoin] and experienced allergies. The patient experienced back pain and muscle weakness on 17Mar2021 23:00, for over 12 days. Went to ER and was admitted to local hospital but discharged after 1 day with dx (diagnosis) of muscle strain in 2021. Symptoms worsened, went to PCP which led to diagnosis of Guillian-Barre Syndrome in 2021 and five days hospitalization for IVIG therapy. The patient was hospitalized for Guillian-Barre Syndrome from 2021 to 2021 for 5 days and for muscle strain, back pain and muscle weakness from 2021 to 2021 for 1 day. The adverse events muscle strain, back pain and muscle weakness resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures were taken as a result of Guillian-Barre Syndrome which included IVIG therapy. The outcome of the events was recovering. The events were considered as serious (hospitalization). Facility where the most recent COVID-19 vaccine was administered was School or Student Health Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Information on the batch/lot number has been requested.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Guillian-Barre Syndrome; Back pain; muscle weakness; muscle strain; This is a spontaneous report received from a contactable consumer (patient). A 58-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration at the age of  58-years-old, administered in Arm Right on 17Mar2021 10:30 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included scoliosis. The patient was not pregnant. Concomitant medications included cranberry (CRANBERRY) and plantago ovata (PSYLLIUM HUSK [PLANTAGO OVATA]), both taken for an unspecified indication, start and stop date were not reported, and an unspecified multivitamin. The patient previously took MACROBID [nitrofurantoin] and experienced allergies. The patient experienced back pain and muscle weakness on 17Mar2021 23:00, for over 12 days. Went to ER and was admitted to local hospital but discharged after 1 day with dx (diagnosis) of muscle strain in 2021. Symptoms worsened, went to PCP which led to diagnosis of Guillian-Barre Syndrome in 2021 and five days hospitalization for IVIG therapy. The patient was hospitalized for Guillian-Barre Syndrome from 2021 to 2021 for 5 days and for muscle strain, back pain and muscle weakness from 2021 to 2021 for 1 day. The adverse events muscle strain, back pain and muscle weakness resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures were taken as a result of Guillian-Barre Syndrome which included IVIG therapy. The outcome of the events was recovering. The events were considered as serious (hospitalization). Facility where the most recent COVID-19 vaccine was administered was School or Student Health Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Information on the batch/lot number has been requested.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Guillain-Barre syndrome, Muscle strain, Muscular weakness
Clinical narrative: Guillian-Barre Syndrome; Back pain; muscle weakness; muscle strain; This is a spontaneous report received from a contactable consumer (patient). A 58-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration at the age of  58-years-old, administered in Arm Right on 17Mar2021 10:30 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included scoliosis. The patient was not pregnant. Concomitant medications included cranberry (CRANBERRY) and plantago ovata (PSYLLIUM HUSK [PLANTAGO OVATA]), both taken for an unspecified indication, start and stop date were not reported, and an unspecified multivitamin. The patient previously took MACROBID [nitrofurantoin] and experienced allergies. The patient experienced back pain and muscle weakness on 17Mar2021 23:00, for over 12 days. Went to ER and was admitted to local hospital but discharged after 1 day with dx (diagnosis) of muscle strain in 2021. Symptoms worsened, went to PCP which led to diagnosis of Guillian-Barre Syndrome in 2021 and five days hospitalization for IVIG therapy. The patient was hospitalized for Guillian-Barre Syndrome from 2021 to 2021 for 5 days and for muscle strain, back pain and muscle weakness from 2021 to 2021 for 1 day. The adverse events muscle strain, back pain and muscle weakness resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures were taken as a result of Guillian-Barre Syndrome which included IVIG therapy. The outcome of the events was recovering. The events were considered as serious (hospitalization). Facility where the most recent COVID-19 vaccine was administered was School or Student Health Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Information on the batch/lot number has been requested.
Age: 99.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: ED visit and hospital admission within 6 weeks of receiving COVID vaccine.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Blood glucose, Computerised tomogram, Dysarthria, Facial paralysis
Clinical narrative: patient had the J/J COVID Vaccine on 3/27. Within 5 minutes of getting the vaccine patient stated she wasn't feeling well, she became pale and diaphoretic and was laid to the ground and feet elevated. She stated she was nauseated, but never had any emesis. She sat up and we took her to the back of the clinic, she stated again that she thought she was going to pass out. Placed her back on the floor where she became pale and diaphoretic again, started to slur her speech and notice R lip droop. Squad and husband was called Patient was transported to  hospital where she was admitted for intermittent facial weakness, slurred speech and right hemiparesis symptoms.  MRI/A negative for stroke/occulision.  Neuro was consulted and felt symptoms were d/t conversion disorder/anxiety.  Patient discharged to Inpatient Rehab for continued weakness
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test, Magnetic resonance imaging, Muscle strength abnormal, Syncope
Clinical narrative: patient had the J/J COVID Vaccine on 3/27. Within 5 minutes of getting the vaccine patient stated she wasn't feeling well, she became pale and diaphoretic and was laid to the ground and feet elevated. She stated she was nauseated, but never had any emesis. She sat up and we took her to the back of the clinic, she stated again that she thought she was going to pass out. Placed her back on the floor where she became pale and diaphoretic again, started to slur her speech and notice R lip droop. Squad and husband was called Patient was transported to  hospital where she was admitted for intermittent facial weakness, slurred speech and right hemiparesis symptoms.  MRI/A negative for stroke/occulision.  Neuro was consulted and felt symptoms were d/t conversion disorder/anxiety.  Patient discharged to Inpatient Rehab for continued weakness
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure decreased, Blood test, Cerebrovascular accident, Computerised tomogram, Dysarthria
Clinical narrative: patient had the J/J COVID Vaccine on 3/27. Within 5 minutes of getting the vaccine patient stated she wasn't feeling well, she became pale and diaphoretic and was laid to the ground and feet elevated. She stated she was nauseated, but never had any emesis. She sat up and we took her to the back of the clinic, she stated again that she thought she was going to pass out. Placed her back on the floor where she became pale and diaphoretic again, started to slur her speech and notice R lip droop. Squad and husband was called Patient was transported to  hospital where she was admitted for intermittent facial weakness, slurred speech and right hemiparesis symptoms.  MRI/A negative for stroke/occulision.  Neuro was consulted and felt symptoms were d/t conversion disorder/anxiety.  Patient discharged to Inpatient Rehab for continued weakness
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial paralysis, Headache, Hyperhidrosis, Hypoaesthesia, Intensive care
Clinical narrative: patient had the J/J COVID Vaccine on 3/27. Within 5 minutes of getting the vaccine patient stated she wasn't feeling well, she became pale and diaphoretic and was laid to the ground and feet elevated. She stated she was nauseated, but never had any emesis. She sat up and we took her to the back of the clinic, she stated again that she thought she was going to pass out. Placed her back on the floor where she became pale and diaphoretic again, started to slur her speech and notice R lip droop. Squad and husband was called Patient was transported to  hospital where she was admitted for intermittent facial weakness, slurred speech and right hemiparesis symptoms.  MRI/A negative for stroke/occulision.  Neuro was consulted and felt symptoms were d/t conversion disorder/anxiety.  Patient discharged to Inpatient Rehab for continued weakness
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Paraesthesia, Syncope
Clinical narrative: patient had the J/J COVID Vaccine on 3/27. Within 5 minutes of getting the vaccine patient stated she wasn't feeling well, she became pale and diaphoretic and was laid to the ground and feet elevated. She stated she was nauseated, but never had any emesis. She sat up and we took her to the back of the clinic, she stated again that she thought she was going to pass out. Placed her back on the floor where she became pale and diaphoretic again, started to slur her speech and notice R lip droop. Squad and husband was called Patient was transported to  hospital where she was admitted for intermittent facial weakness, slurred speech and right hemiparesis symptoms.  MRI/A negative for stroke/occulision.  Neuro was consulted and felt symptoms were d/t conversion disorder/anxiety.  Patient discharged to Inpatient Rehab for continued weakness
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram cerebral normal, Anxiety, Condition aggravated, Conversion disorder, Dizziness
Clinical narrative: patient had the J/J COVID Vaccine on 3/27. Within 5 minutes of getting the vaccine patient stated she wasn't feeling well, she became pale and diaphoretic and was laid to the ground and feet elevated. She stated she was nauseated, but never had any emesis. She sat up and we took her to the back of the clinic, she stated again that she thought she was going to pass out. Placed her back on the floor where she became pale and diaphoretic again, started to slur her speech and notice R lip droop. Squad and husband was called Patient was transported to  hospital where she was admitted for intermittent facial weakness, slurred speech and right hemiparesis symptoms.  MRI/A negative for stroke/occulision.  Neuro was consulted and felt symptoms were d/t conversion disorder/anxiety.  Patient discharged to Inpatient Rehab for continued weakness
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysarthria, Facial paralysis, Facial paresis, Hemiparesis, Hyperhidrosis
Clinical narrative: patient had the J/J COVID Vaccine on 3/27. Within 5 minutes of getting the vaccine patient stated she wasn't feeling well, she became pale and diaphoretic and was laid to the ground and feet elevated. She stated she was nauseated, but never had any emesis. She sat up and we took her to the back of the clinic, she stated again that she thought she was going to pass out. Placed her back on the floor where she became pale and diaphoretic again, started to slur her speech and notice R lip droop. Squad and husband was called Patient was transported to  hospital where she was admitted for intermittent facial weakness, slurred speech and right hemiparesis symptoms.  MRI/A negative for stroke/occulision.  Neuro was consulted and felt symptoms were d/t conversion disorder/anxiety.  Patient discharged to Inpatient Rehab for continued weakness
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging normal, Malaise, Nausea, Pallor
Clinical narrative: patient had the J/J COVID Vaccine on 3/27. Within 5 minutes of getting the vaccine patient stated she wasn't feeling well, she became pale and diaphoretic and was laid to the ground and feet elevated. She stated she was nauseated, but never had any emesis. She sat up and we took her to the back of the clinic, she stated again that she thought she was going to pass out. Placed her back on the floor where she became pale and diaphoretic again, started to slur her speech and notice R lip droop. Squad and husband was called Patient was transported to  hospital where she was admitted for intermittent facial weakness, slurred speech and right hemiparesis symptoms.  MRI/A negative for stroke/occulision.  Neuro was consulted and felt symptoms were d/t conversion disorder/anxiety.  Patient discharged to Inpatient Rehab for continued weakness
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash pruritic, Urticaria
Clinical narrative: I experienced severe hives 3 weeks after my second moderna vaccine.  It started as welts on my thighs and continued with hives on my face, arms, legs, knees, and pubic/groin area. The first shot of moderna had given me the round ring on my left arm, but did not cause hives anywhere else.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: I experienced severe hives 3 weeks after my second moderna vaccine.  It started as welts on my thighs and continued with hives on my face, arms, legs, knees, and pubic/groin area. The first shot of moderna had given me the round ring on my left arm, but did not cause hives anywhere else.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Asthma, Erythema
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Cerebrovascular accident, Eye colour change, Hepatic enzyme, Hepatic enzyme abnormal
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Lung disorder, Migraine
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Intensive care, Peripheral swelling, Throat tightness, Ultrasound Doppler
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood test, Cardiac disorder, Dyskinesia, Dyspnoea
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Erythema, Heart rate, Heart rate abnormal, Hepatic enzyme
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hepatic enzyme abnormal, Migraine, Muscle spasms, Non-pitting oedema, Pain in extremity
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Respiratory disorder, SARS-CoV-2 test, Throat tightness, Weight, Weight increased
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: X-ray
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Alopecia, Bilevel positive airway pressure, Cardiac disorder, Condition aggravated, Dyspnoea
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram abnormal, Fatigue, Fluid retention, Gait disturbance
Clinical narrative: anaphylaxis/anaphylactic condition; abnormal heart problems; vocal cord dyskinesia; SOB; extremely red all over body; Abnormal liver enzymes; Hr became Brady with widening if qtinterval; leg cramps; neuro s/s migraine severe; throat closed; Weight gain 15+ lbs on body non pitting edema; non pitting edema; extreme leg pain; breathing problems; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of bnt162b2 via an unspecified route of administration in right arm on 27Mar2021 16:45 (Lot Number: er8733, expiration date was unknown) as single dose for covid-19 immunisation. Medical history included asthma, brain disorder, arthritis, vertigo. Patient had known allergies. It was unknown if patient had COVID prior vaccination. She was not pregnant at the time of vaccination. Patient did not have other vaccine in four weeks. She used other medications in two weeks. The patient experienced anaphylaxis within 5 minutes went home extreme leg pain. Her throat closed and she had short of breath (SOB). She had extremely red all over body. She went back to emergency department (ED). Electrocardiogram (EKG), X-ray and blood work were done. She had c/o leg cramps. Her weight gain more than 15 lbs on body with non-pitting edema. She received treatment for events. She had abnormal liver enzymes, abnormal heart problems and breathing problems. Anaphylactic condition was to step down was on bipap epi (Epinephrine injection) Benadryl 50 mg every 4 hours and intravenous steroids along with fluids. Renal replacement therapy (RRT) called the next day. Patient didn't remember exact cause. Neuro s/s migraine severe Ajovy taken Uberlvy and not else remembered (as reported). Heart issues maintained and pulmonary showed improvement. Ear, nose, and throat (ENT) consult with scope done showing vocal cord dyskinesia. Heart rate became brady with widening if qt interval. She transferred to telemetry 2 d and echo done. Monitor patient for low heart rate 24 hours. Patient released from hospital on 06Apr2021 evening. At home patient continue to have organs change every 24- 36 hours keeping video monitoring and pictures. All events occurred on 27Mar2021 16:45 and resulted doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization/Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The duration of hospitalization was 6 days. Patient tested COVID-19 via nasal swab on 01Apr2021 with negative result. Benadryl 50 mg she had around the clock, steroids and epi used as treatment. The outcome of all events was not recovered.   No follow up attempts are possible. No further information is expected.